Wilate® (von willebrand factor/coagulation factor VIII complex (human))
for Hemophilia

Wilate (von willebrand factor/coagulation factor VIII complex (human)) is an injection used to treat and prevent bleeding in people with von Willebrand disease or hemophilia A. It can be used for on-demand treatment, routine prophylaxis, and during surgery. Wilate replaces missing von Willebrand factor and factor VIII to help blood clot. VWF supports platelet function and carries FVIII, which is essential for activating clotting proteins.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Hemophilia